natgillin/translations-raw huggingface dataset:
Applicants are exempt from the obligation to submit a product-specific waiver application if the medicine for which they are seeking a marketing authorisation belongs to one of these classes.
Če zdravilo, za katerega vlagatelji želijo odobritev, spada v eno izmed teh skupin, ni treba predložiti vloge za opustitev, specifične za zdravilo.
The Agency is committed to maintaining a strong working relationship with these important stakeholders, and has created a number of mechanisms for their involvement in a range of its activities, including: participating in meetings of the Patients' and Consumers' Working Party or of the Healthcare Professionals' Working Group; checking the quality of information about authorised medicines; assisting in the preparation of regulatory and procedural guidance documents; providing recommendations to the Agency and its scientific committees on all matters of direct or indirect interest to them.
Agencija se je zavezala k ohranjanju trdnega delovnega odnosa s temi pomembnimi interesnimi skupinami je ustvarila številne mehanizme za njihovo vključitev v vrsto svojih dejavnosti, vključno s:
13 related to ‘orphan' medicines, i.e. ones intended for use in the diagnosis, prevention or treatment of rare and seriously debilitating diseases or conditions;
Izmed 103 vlog, prejetih v letu 2008: se jih je 73 nanašalo na zdravila z novo zdravilno učinkovino, tj. kemijsko ali biološko spojino, ki se prej ni uporabila v odobrenem zdravilu; se jih je 13 nanašalo na zdravila „sirote“, tj. zdravila, ki so namenjena uporabi pri diagnostiki, preprečevanju ali zdravljenju redkih in resno izčrpavajočih bolezni ali stanj; se jih je 46 nanašalo na generična ali hibridna zdravila, tj. zdravila, katerih zdravilna učinkovina je v bistvu enaka kot pri prej odobrenem zdravilu; so se 3 nanašale na „podobna biološka zdravila“, tj. zdravila, katerih zdravilno učinkovino izdeluje živ organizem ali je pridobljena iz njega ter je podobna zdravilni učinkovini prej odobrenega zdravila.
If this happens, try again.
Če se to zgodi, poskusite znova.
1.0 unit
1,0 enota
Throw away the bag.
Vrečko zavrzite.
Percentage of Patients who achieved MCID
Odstotek bolnikov, ki so dosegli MCID
Date of first authorisation: 20 July 2012 Date of last renewal: 20 April 2017
Datum prve odobritve: 20. julij 2012 Datum zadnjega podaljšanja: 20. april 2017
A risk to newborns/infants cannot be excluded.
Tveganja za novorojenčke/dojenčke ni možno izključiti.
Some patients may not hear the ‘click'.
Nekateri bolniki morda ne bodo slišali zvoka ‘klik'.
Deterioration of disease:
Poslabšanje bolezni:
It will also help you to remember to use it.
Prav tako vam bo pomagalo, da se spomnite uporabiti zdravilo.
The upper bound of the confidence interval excluded a pre-defined risk margin of 1.8.
Zgornja meja intervala zaupanja je izključevala vnaprej določeno mejo tveganja 1,8.
Therefore, please remember to pay attention to oral hygiene.
Zaradi tega morate biti pozorni na ustno higieno.
This ensures that there is always enough medicine in your body to help you breathe more easily throughout the day and night.
S tem zagotovite vedno dovolj zdravila v svojem telesu, kar vam pomaga, da cel dan in noč lažje dihate.
What should you do if you accidently prepare a dose?
Kaj storiti, če po nesreči pripravite odmerek?
If you want to stop treatment, first talk to your doctor, as your symptoms may worsen.
Če želite zdravljenje prekiniti, se najprej pogovorite z zdravnikom, ker se lahko simptomi poslabšajo.
Allergic reactions may rarely occur (may affect up to 1 in 1,000 people).
Redko lahko pride do alergijskih reakcij (pojavijo se lahko pri največ 1 od 1.000 bolnikov).
How does the dose indicator work?
Kako deluje indikator odmerka?
70.7% of patients completed the study per investigator assessment.
Po raziskovalčevi oceni je študijo dokončalo 70,7 % bolnikov.
Make sure the green button is on top.
Prepričajte se, da je zeleni gumb na vrhu.
2.5 Hold your breath for as long as possible.
2.5 Zadržujte dih kolikor dolgo je mogoče.
How do you know that your inhaler is empty?
Kako veste, da je inhalator prazen?
The study had an event-driven design and was terminated once sufficient MACE events for the primary safety analysis were observed.
Študija je imela z dogodki voden načrt in se je končala, ko je bilo opaženih dovolj dogodkov MACE za primarno analizo varnosti.
Paradoxical bronchospasm:
Paradoksni bronhospazem:
• On first use, every inhaler contains at least 60 doses, or at least 30 doses, depending on the pack size.
• Ob prvi uporabi vsak inhalator vsebuje najmanj 60 odmerkov ali najmanj 30 odmerkov, odvisno od velikosti pakiranja.
If the control window still does not change to red, you may have forgotten to release the green button before inhaling, or you may not have inhaled strongly enough.
Če se kontrolno okence še vedno ne obarva rdeče, ste morda pred inhaliranjem pozabili sprostiti zeleni gumb, ali pa morda niste dovolj močno inhalirali.
For Instructions for Use, see section 6.6.
Za navodila za uporabo, glejte poglavje 6.6.
The recommended dose is one inhalation twice a day in the morning and evening.
Priporočeni odmerek je en vdih dvakrat na dan zjutraj in zvečer.
Control window Red = confirms correct inhalation
Kontrolno okence Rdeča = potrdi pravilno inhalacijo
30 doses 60 doses
30 odmerkov 60 odmerkov
All patients had a history of cardiovascular or cerebrovascular disease and/or significant cardiovascular risk factors.
Vsi bolniki so imeli v anamnezi srčno-žilno ali cerebrovaskularno bolezen in/ali pomembne srčno-žilne dejavnike tveganja.
When you press the button all the way down, the control window changes from red to green.
Ko pritisnite gumb do konca, se kontrolno okence spremeni iz rdečega v zelenega.
The rate of moderate or severe COPD exacerbations per patient per year during the first year of treatment was evaluated as the primary efficacy endpoint in the study.
Delež zmernih ali hudih poslabšanj KOPB na bolnika na leto v prvem letu zdravljenja so ovrednotili kot primarni opazovani dogodek učinkovitosti v študiji.
Never breathe out into the inhaler (Figure I).
Nikoli ne izdihnite v inhalator (Slika I).
NEVER use water to clean the inhaler, as this may damage your medicine.
NIKOLI ne uporabljajte vode za čiščenje inhalatorja, ker lahko poškodujete zdravilo.
If you wish to clean your inhaler, just wipe the outside of the mouthpiece with a dry tissue or paper towel.
Če želite očistiti inhalator, samo obrišite zunanjost ustnika s suho krpo ali papirno brisačo.
Do not tilt.
Ne nagibajte.
59.8% of patients had at least one COPD exacerbation within the past 12 months from the screening visit.
59,8 % bolnikov je imelo v zadnjih 12 mesecih pred presejalnim obiskom vsaj eno poslabšanje KOPB.
b) Do not press the green button until you are ready to take a dose.
b) Ne pritisnite zelenega gumba, dokler niste pripravljeni, da vzamete odmerek.
Control window Green = inhaler ready to use
Kontrolno okence Zelena = inhalator je pripravljen za uporabo
These may be signs of a condition called bronchospasm.
To so lahko znaki stanja, imenovanega bronhospazem.
Dose indicator moves slowly from 60 to 0: 60, 50, 40, 30, 20, 10, 0.
Indikator odmerka se niža v intervalih od 60 do 0: 60, 50, 40, 30, 20, 10, 0.
A ‘click' will let you know that you are inhaling correctly.
‘Klik', ki ga boste zaslišali vam bo dal vedeti, da inhalirate pravilno.
• If your inhaler appears to be damaged or if you lose the cap, or
• Če inhalator izgleda poškodovan ali če ste izgubili pokrovček ali
• Each time you load a dose by pressing the green button, the dose indicator moves by a small amount towards the next number (50, 40, 30, 20, 10, or 0).
• Vsakič, ko s pritiskom na zeleni gumb naložite odmerek, se indikator odmerka za malenkost premakne proti naslednji številki (50, 40, 30, 20, 10, ali 0).
AstraZeneca (AstraZeneca logo)
AstraZeneca (AstraZeneca logotip)
Do not hold the green button down while inhaling.
Ne držite zelenega gumba navzdol, medtem ko inhalirate.
Also contains: Lactose
Vsebuje tudi: laktozo
Read steps 2.1 to 2.7 fully before use.
Pred uporabo v celoti preberite korake 2.1 do 2.7.
These conditions may be affected by the anticholinergic mechanism of action.
Na ta stanja lahko vpliva antiholinergični mehanizem delovanja.
• The dose indicator shows the total number of doses left in the inhaler (Figure N).
• Indikator odmerka kaže skupno število odmerkov, ki so še preostali v inhalatorju (Slika N).
c Odds ratio, increase in the likelihood of achieving the MCID compared to placebo.
c Razmerje verjetnosti, povečanje verjetnosti za MCID v primerjavi s placebom.
This medicine may cause headache, dizziness or blurred vision.
To zdravilo lahko povzroči glavobol, omotico ali zamegljen vid.
1.68-fold c increase in likelihood
1,68-kratno c povečanje verjetnosti
- if you have an enlarged prostate, problems passing urine, or a blockage in your bladder.
- če imate povečano prostato, težave z uriniranjem ali blokado v mehurju.
The frequency of adverse reactions is defined using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data).
Pogostnost neželenih učinkov je opredeljena po naslednjem dogovoru: zelo pogosti (1/10), pogosti (1/100 do <1/10), občasni (1/1.000 do <1/100), redki (1/10.000 do <1/1.000), zelo redki (<1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
The mouthpiece is covered with a removable green protective cap.
Ustnik je prekrit z odstranljivim zelenim zaščitnim pokrovčkom.
Aclidinium bromide should only be used during pregnancy if the expected benefits outweigh the potential risks.
Aklidinijev bromid se lahko uporablja med nosečnostjo samo, če se pričakuje, da koristi odtehtajo morebitna tveganja.
The use of Bretaris Genuair with these medicines is not recommended.
Uporaba zdravila Bretaris Genuair s temi zdravili ni priporočena.
Then take a strong, deep breath through the mouthpiece.
Nato močno in globoko vdihnite skozi ustnik.
1.87-fold c increase in likelihood
1,87-kratno c povečanje verjetnosti
The safety margins for human systemic exposure with 400 µg twice daily over the no observed adverse effect levels in these studies ranged from 7- to 73-fold.
Varnostna rezerva za človeško sistemsko izpostavljenost z odmerkom 400 µg dvakrat na dan nad mero brez opaženih neželenih učinkov v teh študijah je bila od 7- do 73-kratna.
1.1 Look in the opening of the mouthpiece and make sure nothing is blocking it (Figure C).
1.1 Poglejte v odprtino ustnika in se prepričajte, da ga nič ne ovira (Slika C).
c) Pull off the cap by lightly squeezing the arrows marked on each side (Figure B).
c) Odstranite pokrovček, tako da rahlo stisnete puščici, označeni na vsaki strani (Slika B).
Make sure you have released the green button, and you have breathed out completely.
Preverite, da ste sprostili zeleni gumb in da ste v celoti izdihnili.
Squeeze here and pull
Tukaj pritisnite in povlecite
The occurrence of headache, dizziness or blurred vision following administration of aclidinium bromide (see section 4.8) may influence the ability to drive or to use machinery.
Pojav glavobola, omotice ali zamegljenega vida po dajanju aklidinijevega bromida (glejte poglavje 4.8) lahko vpliva na sposobnost vožnje ali upravljanja strojev.
Pharmacotherapeutic group: Drugs for obstructive airway diseases, anticholinergics; ATC Code: R03BB05.
Farmakoterapevtska skupina: zdravila za obstruktivne pljučne bolezni, antiholinergiki; oznaka ATC: R03BB05.
It is important that you read this information as the Genuair may work differently from inhalers you have used previously.
Pomembno je, da si preberete te informacije, saj lahko Genuair deluje drugače od inhalatorjev, ki ste jih že uporabljali.
Go back to ‘STEP 1 Prepare your dose' and repeat steps 1.1 to 1.6.
Vrnite se na ‘KORAK 1 Priprava odmerka' in ponovite korake 1.1 do 1.6.
How should you clean the inhaler?
Kako je treba čistiti inhalator?
Push the protective cap back onto the mouthpiece after each use (Figure M), to prevent contamination of the inhaler with dust or other materials.
Po vsaki uporabi pritisnite zaščitni pokrovček nazaj na ustnik (Slika M), da preprečite kontaminacijo inhalatorja s prahom ali drugimi snovmi.
Make sure you release the button so the inhaler can work correctly.
Prepričajte se, da ste sprostili gumb, da bo inhalator lahko deloval pravilno.
The recommended dose can be used for elderly patients and for patients with kidney or liver problems.
Priporočen odmerek lahko uporabljajo tudi starejši bolniki in bolniki z ledvičnimi oziroma jetrnimi težavami.
Even though the green button is locked, your last dose may still be inhaled.
Tudi če je zeleni gumb zaklenjen, lahko še vedno vdihnete zadnji odmerek.
Do not use this medicine after the expiry date which is stated on the inhaler label and carton after “EXP”.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na nalepki inhalatorja in škatli poleg oznake „EXP“.
After that, the inhaler cannot be used again and you should start using a new inhaler.
Po tem inhalatorja ne morete več uporabljati, zato začnite uporabljati nov inhalator.
• If your inhaler is empty (Figure O).
• Če je inhalator prazen (Slika O).
Keep breathing in for as long as possible.
Nadaljujte z vdihovanjem kolikor dolgo je mogoče.
This means you have not inhaled your medicine correctly.
To pomeni, da zdravila niste pravilno inhalirali.
It is supplied in a plastic pouch.
Pakiran je v plastični vrečki.
The dose is not prepared.
Odmerek ni pripravljen.
You can use Bretaris Genuair any time before or after food or drink.
Zdravilo Bretaris Genuair lahko uporabite kadar koli pred uživanjem hrane ali pijače ali po tem.
It is important to instruct the patients to carefully read the Instructions for Use in the Package Leaflet, which is packed together with each inhaler.
Pomembno je bolnike podučiti, da natančno preberejo navodila za uporabo v Navodilu za uporabo, ki je priloženo vsakemu inhalatorju.
Maximal bronchodilatory effects were evident from day one and were maintained over the 6-month treatment period.
Maksimalni učinki bronhodilatacije so bili očitni od prvega dne in so ostali prisotni celotno 6-mesečno obdobje zdravljenja.
What to do if the control window is still red after pressing the button (Figure H).
Kaj storiti, če je kontrolno okence še vedno obarvano rdeče po tem, ko ste že pritisnili gumb (Slika H).
Patients discontinued treatment if they experienced a MACE event and entered into the post-treatment follow-up period during the study.
Če so bolniki doživeli dogodek MACE, so prenehali prejemati zdravilo in so vstopili v obdobje spremljanja po zdravljenju v okviru študije.
If your COPD symptoms (breathlessness, wheezing, cough) do not improve or get worse you should contact your doctor for advice as soon as possible.
Če se simptomi KOPB (zasoplost, piskajoče dihanje, kašelj) ne izboljšajo ali se poslabšajo, se čim prej posvetujte z zdravnikom.
Become familiar with the parts of your Genuair inhaler.
Seznanite se s sestavnimi deli vašega inhalatorja Genuair.
Some patients may experience a grainy sensation in their mouth, or a slightly sweet or bitter taste.
Nekateri bolniki lahko v ustih občutijo zrnavost ali pa okusijo rahlo sladek ali grenak okus.
The fraction of the inhaled dose that reaches the systemic circulation as unchanged aclidinium is very low at less than 5%.
Delež vdihanega odmerka, ki doseže sistemski krvni obtok kot nespremenjeni aklidinij, je zelo nizek in manjši od 5 %.
In the event of a change in COPD intensity while the patient is being treated with aclidinium bromide so that the patient considers additional rescue medication is required, a re-evaluation of the patient and the patients' treatment regimen should be conducted.
Če je sprememba intenzivnosti KOPB med zdravljenjem bolnika z aklidinijevim bromidom tolikšna, da bolnik razmišlja o dodatnem reševalnem zdravilu, je treba ponovno ovrednotiti režim zdravljenja bolnika.
Excipients with known effect Each delivered dose contains approximately 12 mg lactose (as monohydrate).
Pomožna snov z znanim učinkom: En dostavljen odmerek vsebuje približno 12 mg laktoze (v obliki monohidrata).
Approximately 48% of enrolled patients had a prior history of at least 1 documented previous cardiovascular event; cerebrovascular disease (13.1%), coronary artery disease (35.4%), peripheral vascular disease or history of claudication (13.6%).
Približno 48 % vključenih bolnikov je imelo anamnezo vsaj 1 dokumentiranega srčno-žilnega dogodka, cerebrovaskularno bolezen (13,1 %), koronarno bolezen (35,4 %), periferno žilno bolezen ali anamnezo klavdikacije (13,6 %).
If this occurs, treatment with Bretaris Genuair should be stopped and other treatments considered.
Če pride do tega, je treba zdravljenje z zdravilom Bretaris Genuair prekiniti in razmisliti o drugih terapijah.
Locked
Zaklenjeno
Patients should be instructed on how to administer the product correctly as the Genuair inhaler may work differently from inhalers the patients may have used previously.
Bolnike je treba poučiti o tem, kako pravilno vzamejo zdravilo, ker lahko inhalator Genuair deluje drugače od inhalatorjev, ki so jih bolniki že prej uporabljali.
If you are affected by any of these side effects do not drive or use machinery until the headache has cleared, the feeling of dizziness has passed and your vision has returned to normal.
Če imate katerega koli od teh neželenih učinkov, ne vozite in ne upravljajte strojev, dokler glavobol ali omotica ne mine in se povrne normalen vid.
How to store Bretaris Genuair Contents of the pack and other information Instructions for Use
Shranjevanje zdravila Bretaris Genuair Vsebina pakiranja in dodatne informacije Navodila za uporabo
2.2 Hold your head upright, put the mouthpiece between your lips, and close your lips tightly around it (Figure J).
2.2 Držite glavo pokonci, vstavite ustnik med ustnici in tesno sklenite ustnice okrog ustnika (Slika J).
Children and adolescents Bretaris Genuair is not for use in children or adolescents below 18 years of age.
Otroci in mladostniki Zdravilo Bretaris Genuair ni namenjeno za otroke ali mladostnike do 18. leta starosti.
This makes it easier for chronic obstructive pulmonary disease (COPD) patients to breathe.
Zaradi tega bolniki s kronično obstruktivno pljučno boleznijo (KOPB) lažje dihajo.
2.1 Hold the inhaler away from your mouth, and breathe out completely.
2.1 Držite inhalator stran od svojih ust in v celoti izdihnite.
Your medicine is ready to be inhaled.
Vaše zdravilo je sedaj pripravljeno za inhaliranje.
Use the control window to ensure you have inhaled correctly.
Poglejte kontrolno okence, da se prepričate ali ste pravilno inhalirali.
This leaflet was last revised in <{month YYYY}>.
Navodilo je bilo nazadnje revidirano dne {mesec LLLL}.
You should not use Bretaris Genuair if you are pregnant or are breast-feeding unless your doctor tells you so.
Zdravila Bretaris Genuair ne smete uporabljati, če ste noseči ali dojite, razen če vam tako ne naroči zdravnik.
08740 Sant Andreu de la Barca, Barcelona Spain
08740 Sant Andreu de la Barca, Barcelona Španija
When should you get a new inhaler?
Kdaj začeti uporabljati nov inhalator?
Do not use Bretaris Genuair - if you are allergic to aclidinium bromide or any of the other ingredients of this medicine (listed in section 6).
Ne uporabljajte zdravila Bretaris Genuair - če ste alergični na aklidinijev bromid ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Regular use of Bretaris Genuair can help you when you have ongoing shortness of breath related to your disease to help you minimise the effects of the disease on your everyday life and reduce the number of flare-ups (the worsening of your COPD symptoms for several days).
Redna uporaba zdravila Bretaris Genuair vam lahko pomaga, kadar imate dolgotrajnejše težave z zadihanostjo, ki je povezana z vašo boleznijo, in vam pomaga zmanjšati učinke bolezni na vaše vsakdanje življenje ter zmanjšati število poslabšanj (poslabšanje simptomov KOPB za več dni).
The inhaler device is a multicomponent device made of polycarbonate, acrylonitrile-butadiene-styrene, polyoxymethylene, polyester-butylene-terephthalate, polypropylene, polystyrene and stainless steel.
Inhalacijski pripomoček sestavlja več kosov iz polikarbonata, akrilonitril-butadien-stirena, polioksimetilena, poliester-butilen-tereftalata, polipropilena, polistirena in nerjavnega jekla.
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Bretaris Genuair therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.
Odločiti se je treba bodisi za prenehanje dojenja bodisi za prekinitev/prenehanje zdravljenja z zdravilom Bretaris Genuair, pri čemer je treba pretehtati prednosti dojenja za otroka in prednosti zdravljenja za mater.
This means you have inhaled your medicine correctly.
To pomeni, da ste pravilno inhalirali zdravilo.
b MCID of at least - 4 units change in SGRQ.
b MCID, ki znaša vsaj -4 enote spremembe vrednosti SGRQ.
The European Medicines Agency has waived the obligation to submit the results of studies with Bretaris Genuair in all subsets of the paediatric population in COPD (see section 4.2 for information on paediatric use).
Evropska agencija za zdravila je odstopila od obveze za predložitev rezultatov študij z zdravilom Bretaris Genuair za vse podskupine pediatrične populacije s KOPB (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
Aclidinium bromide demonstrated kinetic linearity and a time-independent pharmacokinetic behaviour in the therapeutic range.
Aklidinijev bromid je pokazal kinetično linearnost in časovno neodvisno farmakokinetično obnašanje v terapevtskem razponu.
Check mouthpiece opening
Preverite odprtino ustnika
Following repeated inhalations, the systemic exposure of aclidinium bromide has been observed to be similar in Japanese and Caucasian patients.
Po ponavljajočih inhalacijah je bila opažena podobna sistemska izpostavljenost aklidinijevega bromida pri japonskih in belopoltih bolnikih.
Up to 65% of the dose was eliminated as metabolites in the urine and up to 33% as metabolites in the faeces.
Do 65 % odmerka se je izločilo v obliki presnovkov z urinom, do 33 % pa v obliki presnovkov v blatu.
Aclidinium bromide is rapidly absorbed from the lung, achieving maximum plasma concentrations within 5 minutes of inhalation in healthy subjects, and normally within the first 15 minutes in COPD patients.
Aklidinijev bromid se hitro absorbira iz pljuč in doseže največjo koncentracijo v plazmi v 5 minutah po inhalaciji pri zdravih ljudeh in običajno v prvih 15 minutah pri bolnikih s KOPB.
Cardiovascular effects:
Srčno-žilni učinki:
1.2 Look at the control window (should be red, Figure C).
1.2 Poglejte kontrolno okence (mora biti obarvano rdeče, Slika C).
Administration of Bretaris Genuair may cause paradoxical bronchospasm.
Dajanje zdravila Bretaris Genuair lahko povzroči paradoksni bronhospazem.
The most frequently reported adverse reactions with Bretaris Genuair were headache (6.6%) and nasopharyngitis (5.5%).
Najpogosteje poročana neželena učinka zdravila Bretaris Genuair sta bila glavobol (6,6 %) in nazofaringitis (5,5 %).
STEP 1: Prepare your dose
KORAK 1: Priprava odmerka
Biotransformation via CYP450 enzymes plays a minor role in the total metabolic clearance of aclidinium bromide.
Biološka transformacija prek encimov CYP450 igra manjšo vlogo pri skupnem presnovnem očistku aklidinijevega bromida.
1.5 Release the green button (Figure F).
1.5 Sprostite zeleni gumb (Slika F).
High doses of aclidinium bromide may lead to anticholinergic signs and symptoms.
Veliki odmerki aklidinijevega bromida lahko povzročijo antiholinergične znake in simptome.
2.6 Slowly breathe out away from the inhaler.
2.6 Počasi izdihnite proč od inhalatorja.
Go back to ‘STEP 2 Inhale your medicine' and repeat steps 2.1 to 2.7.
Vrnite se na ‘KORAK 2 Inhaliranje odmerka vašega zdravila' in ponovite korake 2.1 do 2.7.